PricewaterhouseCoopers (01358): Proposed termination of the listing of Sichuan Ruijian Healthcare

Zhitong Finance App News, Puhua Heshun (01358) issued an announcement. The board of directors of the company recently received a notice from Sichuan Ruijian Medical Technology Co., Ltd. (Sichuan Ruijian Medical, a non-wholly-owned subsidiary of the company, whose shares are listed in the National SME Share Transfer System (New Third Board), the stock code is 874652), announcing that on October 21, 2026, the board of directors of Sichuan Ruijian Medical decided: (i) Proposed voluntary termination of the listing; (ii) Measures to protect Sichuan Ruijian Healthcare, which has objections to the termination of the listing; (ii) Measures to protect Sichuan Ruijian Healthcare, which has objections to the termination of the listing shareholders' rights;

(iii) Seek authorization from the shareholders of Sichuan Ruijian Medical from its board of directors to handle all matters relating to the proposed termination of listing; (iv) Hold the 5th Extraordinary General Meeting of Shareholders of Sichuan Ruijian Medical in 2026, which is expected to be held on November 6, 2026 to review and approve the above matters as appropriate.

Sichuan Ruijian Medical is a medical device company, mainly engaged in R&D, manufacturing and sales of medical devices for blood purification. As of the date of this announcement, the company indirectly held about 53.10% of all issued shares of Sichuan Ruijian Medical. Sichuan Ruijian Medical is a non-wholly-owned subsidiary of the company, and its financial results are incorporated into the Group's financial statements.